Drug
Kalinox
Kalinox is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_2
2
67%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (66.7%)
N/A1 (33.3%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Interest of Virtual Reality in the Management of Anxiety and Pain Related to Post-cardiac Surgery Care
NCT03956264
completedphase_2
Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients
NCT03755895
completedphase_2
Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)
NCT03483194
Clinical Trials (3)
Showing 3 of 3 trials
NCT03956264Not Applicable
Interest of Virtual Reality in the Management of Anxiety and Pain Related to Post-cardiac Surgery Care
NCT03755895Phase 2
Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients
NCT03483194Phase 2
Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3